Additional file 1: of Efficacy and safety of rasagiline in Chinese patients with early Parkinsonâs disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

Zhang, Zhenxin; Wang, Jian; Chen, Shengdi; Liu, Chunfeng; Zhang, Baorong; Peng, Rong; Sun, Shenggang; Sun, Xiangru; Zhao, Gang; Qu, Qiumin; Li, Yansheng; Zhu, Suiqiang; Pan, Xiaoping; Shao, Ming; Wang, Yanping

doi:10.6084/m9.figshare.7428518.v1

sorry, we can't preview this file

40035_2018_137_MOESM1_ESM.doc (32 kB)

Additional file 1: of Efficacy and safety of rasagiline in Chinese patients with early Parkinsonâs disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study

journal contribution

posted on 2018-12-06, 05:00 authored by Zhenxin Zhang, Jian Wang, Shengdi Chen, Chunfeng Liu, Baorong Zhang, Rong Peng, Shenggang Sun, Xiangru Sun, Gang Zhao, Qiumin Qu, Yansheng Li, Suiqiang Zhu, Xiaoping Pan, Ming Shao, Yanping Wang

List of study sites. (DOC 32 kb)

Funding

H. Lundbeck A/S (Copenhagen, Denmark)

History

Usage metrics

Keywords

Parkinsonâs disease Monoamine oxidase inhibitor Rasagiline Monotherapy China

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC